Jpmorgan Chase & CO Anika Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 15,509 shares of ANIK stock, worth $264,583. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,509

Previous 26,581 41.65%

Holding current value

$264,583

Previous $673,000 43.09%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 26, 2024	SELL	$24.25 - $28.75 $268,496 - $318,320	-11,072 Reduced 41.65%	15,509 $383,000
Q3 2024 Nov 08, 2024	SELL	$24.25 - $28.75 $268,496 - $318,320	-11,072 Reduced 41.65%	15,509 $383,000
Q2 2024 Dec 26, 2024	BUY	$24.57 - $28.47 $272,039 - $315,219	11,072 Added 71.39%	26,581 $673,000
Q2 2024 Aug 12, 2024	SELL	$24.57 - $28.47 $19,508 - $22,605	-794 Reduced 2.9%	26,581 $673,000
Q1 2024 Dec 26, 2024	BUY	$21.95 - $26.42 $260,458 - $313,499	11,866 Added 76.51%	27,375 $695,000
Q1 2024 May 10, 2024	SELL	$21.95 - $26.42 $65,279 - $78,573	-2,974 Reduced 9.8%	27,375 $695,000
Q4 2023 Dec 26, 2024	BUY	$18.47 - $23.3 $274,094 - $345,772	14,840 Added 95.69%	30,349 $687,000
Q4 2023 Feb 12, 2024	BUY	$18.47 - $23.3 $295,833 - $373,196	16,017 Added 111.76%	30,349 $687,000
Q3 2023 Nov 14, 2023	SELL	$16.98 - $26.1 $63,505 - $97,614	-3,740 Reduced 20.69%	14,332 $267,000
Q2 2023 Aug 11, 2023	BUY	$25.16 - $28.86 $78,901 - $90,504	3,136 Added 21.0%	18,072 $469,000
Q1 2023 May 18, 2023	BUY	$25.91 - $32.1 $289,336 - $358,460	11,167 Added 296.29%	14,936 $428,000
Q1 2023 May 11, 2023	SELL	$25.91 - $32.1 $194,195 - $240,589	-7,495 Reduced 66.54%	3,769 $108,000
Q4 2022 Feb 13, 2023	BUY	$23.85 - $31.91 $15,693 - $20,996	658 Added 6.2%	11,264 $334,000
Q3 2022 Nov 14, 2022	BUY	$21.74 - $24.68 $18,609 - $21,126	856 Added 8.78%	10,606 $253,000
Q2 2022 Aug 11, 2022	BUY	$20.4 - $25.53 $24,439 - $30,584	1,198 Added 14.01%	9,750 $218,000
Q1 2022 May 11, 2022	SELL	$24.7 - $36.54 $30,282 - $44,798	-1,226 Reduced 12.54%	8,552 $215,000
Q4 2021 Feb 10, 2022	BUY	$35.83 - $45.03 $112,577 - $141,484	3,142 Added 47.35%	9,778 $350,000
Q3 2021 Nov 12, 2021	BUY	$38.75 - $44.47 $257,145 - $295,102	6,636 New	6,636 $282,000

Others Institutions Holding ANIK

# of Institutions

124

Shares Held

11.4M

Call Options Held

200

Put Options Held

100

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $249M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Anika Therapeutics, Inc. Transaction History